Skip to content
Sign inOpen the app
Pharmaceutical Executive

Pharmaceutical Executive Daily: FDA Approves Orezeyful

Yesterday · 2 min · 2.7 MB
0:00-2:53

Streams straight from the publisher. podnod never proxies or re-hosts episode audio.

Open in podnod

In today's Pharmaceutical Executive Daily, an antitrust attorney weighs the legal risks of a hypothetical AstraZeneca-Bristol Myers Squibb merger, Eli Lilly beats Wall Street estimates on soaring Mounjaro and Zepbound sales and raises its full-year guidance, and the FDA approves Moderna's first mRNA-based flu vaccine for adults 50 and older.